Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 6/2015

01.12.2015 | Clinical Investigation

Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

verfasst von: Zhijun Wang, Rongxin Chen, Rafael Duran, Yan Zhao, Gayane Yenokyan, Julius Chapiro, Rüdiger Schernthaner, Alessandro Radaelli, MingDe Lin, Jean-François Geschwind

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate whether intraprocedural 3D quantification of Lipiodol deposition on cone-beam computed tomography (CBCT) can predict tumor response on follow-up contrast-enhanced magnetic resonance imaging (CE-MRI) in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE).

Materials and Methods

This IRB approved, retrospective analysis included 36 patients with 51 HCC target lesions, who underwent cTACE with CBCT. CE-MRI was acquired at baseline and 1 month after cTACE. Overall tumor volumes as well as intratumoral Lipiodol volumes on CBCT were measured and compared with the overall and necrotic (non-enhancing) tumor volumes on CE-MRI using the paired student’s t test. Tumor response on CE-MRI was assessed using modified response evaluation criteria in solid tumors (mRECIST). A linear regression model was used to correlate tumor volumes, Lipiodol volumes, and the percentage of Lipiodol deposition on CBCT with the corresponding parameters on CE-MRI. Nonparametric spearman rank-order correlation and trend test were used to correlate the percentage of Lipiodol deposition in the tumor with tumor response.

Result

A strong correlation between overall tumor volumes on CBCT and CE-MRI was observed (R 2 = 0.986). In addition, a strong correlation was obtained between the volume of Lipiodol deposition on CBCT and tumor necrosis (in cm3) on CE-MRI (R 2 = 0.960), and between the percentage of Lipiodol deposition and tumor necrosis (R 2 = 0.979). Importantly, the extent of Lipiodol deposition (in percentage of total tumor volume) correlated strongly with tumor response on CE-MRI (Spearman rho = 0.84, p < 0.001).

Conclusions

Intraprocedural 3D quantification of Lipiodol deposition on CBCT can be used to predict tumor response on follow-up CE-MRI.
Literatur
1.
Zurück zum Zitat Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9. doi:10.1016/S0140-6736(02)08649-X.CrossRefPubMed Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9. doi:10.​1016/​S0140-6736(02)08649-X.CrossRefPubMed
2.
Zurück zum Zitat Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71. doi:10.1053/jhep.2002.33156.CrossRefPubMed Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71. doi:10.​1053/​jhep.​2002.​33156.CrossRefPubMed
3.
Zurück zum Zitat Herber S, Biesterfeld S, Franz U, Schneider J, Thies J, Schuchmann M, et al. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Interv Radiol. 2008;31(4):768–77. doi:10.1007/s00270-007-9270-8.CrossRef Herber S, Biesterfeld S, Franz U, Schneider J, Thies J, Schuchmann M, et al. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Interv Radiol. 2008;31(4):768–77. doi:10.​1007/​s00270-007-9270-8.CrossRef
4.
Zurück zum Zitat Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176(3):681–8. doi:10.2214/ajr.176.3.1760681.CrossRefPubMed Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176(3):681–8. doi:10.​2214/​ajr.​176.​3.​1760681.CrossRefPubMed
5.
Zurück zum Zitat Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology. 2013;266(2):636–48. doi:10.1148/radiol.12112316.PubMedCentralCrossRefPubMed Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology. 2013;266(2):636–48. doi:10.​1148/​radiol.​12112316.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Yamanaka K, Hatano E, Kitamura K, Iida T, Ishii T, Machimito T, et al. Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma. J Gastroenterol. 2012;47(3):343–6. doi:10.1007/s00535-011-0511-x.CrossRefPubMed Yamanaka K, Hatano E, Kitamura K, Iida T, Ishii T, Machimito T, et al. Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma. J Gastroenterol. 2012;47(3):343–6. doi:10.​1007/​s00535-011-0511-x.CrossRefPubMed
8.
Zurück zum Zitat Monsky WL, Kim I, Loh S, Li CS, Greasby TA, Deutsch LS, et al. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol. 2010;195(5):1220–30. doi:10.2214/AJR.09.3964.CrossRefPubMed Monsky WL, Kim I, Loh S, Li CS, Greasby TA, Deutsch LS, et al. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol. 2010;195(5):1220–30. doi:10.​2214/​AJR.​09.​3964.CrossRefPubMed
9.
Zurück zum Zitat Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol : Off J Am Soc Clin Oncol. 2002;20(22):4459–65.CrossRef Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol : Off J Am Soc Clin Oncol. 2002;20(22):4459–65.CrossRef
10.
Zurück zum Zitat El Khaddari S, Gaudin JL, Abidi H, Picaud G, Rode A, Souquet JC. Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session. Gastroenterol Clin Biol. 2002;26(8–9):728–34.PubMed El Khaddari S, Gaudin JL, Abidi H, Picaud G, Rode A, Souquet JC. Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session. Gastroenterol Clin Biol. 2002;26(8–9):728–34.PubMed
11.
Zurück zum Zitat Oh JS, Chun HJ, Choi BG, Lee HG. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. J Vascu Interv Radiol JVIR. 2013;24(4):483–9. doi:10.1016/j.jvir.2013.01.001.CrossRef Oh JS, Chun HJ, Choi BG, Lee HG. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. J Vascu Interv Radiol JVIR. 2013;24(4):483–9. doi:10.​1016/​j.​jvir.​2013.​01.​001.CrossRef
12.
Zurück zum Zitat Kim DY, Ryu HJ, Choi JY, Park JY, Lee DY, Kim BK, et al. Radiological response predicts survival following transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther. 2012;35(11):1343–50.CrossRefPubMed Kim DY, Ryu HJ, Choi JY, Park JY, Lee DY, Kim BK, et al. Radiological response predicts survival following transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther. 2012;35(11):1343–50.CrossRefPubMed
13.
Zurück zum Zitat Tacher V, Radaelli A, Lin M, Geschwind J-F. How I do it: cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015;274(2):320–34.PubMedCentralCrossRefPubMed Tacher V, Radaelli A, Lin M, Geschwind J-F. How I do it: cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015;274(2):320–34.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Loffroy R, Lin M, Rao P, Bhagat N, Noordhoek N, Radaelli A, et al. Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Interv Radiol. 2012;35(1):97–104. doi:10.1007/s00270-011-0118-x.CrossRef Loffroy R, Lin M, Rao P, Bhagat N, Noordhoek N, Radaelli A, et al. Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Interv Radiol. 2012;35(1):97–104. doi:10.​1007/​s00270-011-0118-x.CrossRef
16.
Zurück zum Zitat Chen R, Geschwind JF, Wang Z, Tacher V, Lin M. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT. J Vascu Interv Radiol : JVIR. 2013;24(12):1837–44. doi:10.1016/j.jvir.2013.08.017.CrossRef Chen R, Geschwind JF, Wang Z, Tacher V, Lin M. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT. J Vascu Interv Radiol : JVIR. 2013;24(12):1837–44. doi:10.​1016/​j.​jvir.​2013.​08.​017.CrossRef
19.
Zurück zum Zitat Lin M, Pellerin O, Bhagat N, Rao PP, Loffroy R, Ardon R, et al. Quantitative and volumetric European association for the study of the liver and response evaluation criteria in solid tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization. J Vascu Interve Radiol : JVIR. 2012;23(12):1629–37. doi:10.1016/j.jvir.2012.08.028.CrossRef Lin M, Pellerin O, Bhagat N, Rao PP, Loffroy R, Ardon R, et al. Quantitative and volumetric European association for the study of the liver and response evaluation criteria in solid tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization. J Vascu Interve Radiol : JVIR. 2012;23(12):1629–37. doi:10.​1016/​j.​jvir.​2012.​08.​028.CrossRef
20.
Zurück zum Zitat Chapiro J, Wood LD, Lin M, Duran R, Cornish T, Lesage D, et al. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology. 2014;273(3):746–58.PubMedCentralCrossRefPubMed Chapiro J, Wood LD, Lin M, Duran R, Cornish T, Lesage D, et al. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology. 2014;273(3):746–58.PubMedCentralCrossRefPubMed
22.
24.
Zurück zum Zitat Chapiro J, Lin M, Duran R, Schernthaner RE, Geschwind J-F. Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI. Expert Rev Anticancer Ther. 2014;15(2):199–205. Chapiro J, Lin M, Duran R, Schernthaner RE, Geschwind J-F. Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI. Expert Rev Anticancer Ther. 2014;15(2):199–205.
25.
Zurück zum Zitat Gillmore R, Stuart S, Kirkwood A, Hameeduddin A, Woodward N, Burroughs AK, et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol. 2011;55(6):1309–16. doi:10.1016/j.jhep.2011.03.007.CrossRefPubMed Gillmore R, Stuart S, Kirkwood A, Hameeduddin A, Woodward N, Burroughs AK, et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol. 2011;55(6):1309–16. doi:10.​1016/​j.​jhep.​2011.​03.​007.CrossRefPubMed
26.
Zurück zum Zitat Guo Y, Yaghmai V, Salem R, Lewandowski RJ, Nikolaidis P, Larson AC, et al. Imaging tumor response following liver-directed intra-arterial therapy. Abdom Imaging. 2013;38(6):1286–99. doi:10.1007/s00261-013-0017-5 PMID: WOS:000328076000014.CrossRefPubMed Guo Y, Yaghmai V, Salem R, Lewandowski RJ, Nikolaidis P, Larson AC, et al. Imaging tumor response following liver-directed intra-arterial therapy. Abdom Imaging. 2013;38(6):1286–99. doi:10.​1007/​s00261-013-0017-5 PMID: WOS:000328076000014.CrossRefPubMed
27.
Zurück zum Zitat Chung JC, Naik NK, Lewandowski R, Deng J, Mulcahy MF, Kulik LM, et al. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroentero. 2010;16(25):3161–7. doi:10.3748/wjg.v16.i25.3161 PMID: WOS:000279765300008.CrossRef Chung JC, Naik NK, Lewandowski R, Deng J, Mulcahy MF, Kulik LM, et al. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroentero. 2010;16(25):3161–7. doi:10.​3748/​wjg.​v16.​i25.​3161 PMID: WOS:000279765300008.CrossRef
28.
Zurück zum Zitat Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate? Eur Radiol. 2009;19(7):1809–16. doi:10.1007/s00330-009-1327-4.CrossRefPubMed Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate? Eur Radiol. 2009;19(7):1809–16. doi:10.​1007/​s00330-009-1327-4.CrossRefPubMed
29.
Zurück zum Zitat Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, et al. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology. 2013;268(2):431–9. doi:10.1148/radiol.13121637.CrossRefPubMed Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, et al. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology. 2013;268(2):431–9. doi:10.​1148/​radiol.​13121637.CrossRefPubMed
30.
Zurück zum Zitat Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology. 2002;225(2):416–9. doi:10.1148/radiol.2252011604.CrossRefPubMed Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology. 2002;225(2):416–9. doi:10.​1148/​radiol.​2252011604.CrossRefPubMed
31.
Zurück zum Zitat Duran R, Chapiro J, Frangakis C, Lin M, Schlachter TR, Schernthaner RE, et al. Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization. Transl Oncol. 2014;7(4):447–55. doi:10.1016/j.tranon.2014.05.004.PubMedCentralCrossRefPubMed Duran R, Chapiro J, Frangakis C, Lin M, Schlachter TR, Schernthaner RE, et al. Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization. Transl Oncol. 2014;7(4):447–55. doi:10.​1016/​j.​tranon.​2014.​05.​004.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Jeon UB, Lee JW, Choo KS, Kim CW, Kim S, Lee TH, et al. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas. World J Gastroenterol : WJG. 2009;15(46):5833–7.PubMedCentralCrossRefPubMed Jeon UB, Lee JW, Choo KS, Kim CW, Kim S, Lee TH, et al. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas. World J Gastroenterol : WJG. 2009;15(46):5833–7.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Kim S, Yoshizumi TT, Toncheva G, Yoo S, Yin FF. Comparison of radiation doses between cone beam CT and multi detector CT: TLD measurements. Radiat Prot Dosim. 2008;132(3):339–45. doi:10.1093/rpd/ncn305.CrossRef Kim S, Yoshizumi TT, Toncheva G, Yoo S, Yin FF. Comparison of radiation doses between cone beam CT and multi detector CT: TLD measurements. Radiat Prot Dosim. 2008;132(3):339–45. doi:10.​1093/​rpd/​ncn305.CrossRef
Metadaten
Titel
Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
verfasst von
Zhijun Wang
Rongxin Chen
Rafael Duran
Yan Zhao
Gayane Yenokyan
Julius Chapiro
Rüdiger Schernthaner
Alessandro Radaelli
MingDe Lin
Jean-François Geschwind
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 6/2015
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-015-1129-9

Weitere Artikel der Ausgabe 6/2015

CardioVascular and Interventional Radiology 6/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.